NPI registry status
Active
2026 NPPES data Child & Adolescent Psychiatry Physician NPI 1215377338 MD
Verify on CMS → Sandra Cammarata, MD
Child & Adolescent Psychiatry Physician in Caldwell, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 6,300 in Child & Adolescent Psychiatry Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
859
Medicare Part D claims · 53 beneficiaries · Child & Adolescent Psychiatry Physician avg: 608
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$125.35
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Sandra Cammarata, MD filed 859 Medicare Part D claims in 2024 as a Child & Adolescent Psychiatry Physician in Caldwell, New Jersey, prescribing 84% generic.
- 859
- Part D claims, 2024
- 84%
- generic prescribing
- $125.35
- industry payments (Sunshine Act)
- ≥72nd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Sandra Cammarata, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1215377338), first enumerated 07/03/2013.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 859 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$125.35 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1215377338 · Child & Adolescent Psychiatry Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1215377338
- ENUM-MID 2013
- TAX-MID 6K Child &
- RX-LIGHT 859
- BOOK-THIN 180 in New Jersey
- PHOTO-ENUM Natalie Pon · 2013
Sandra Cammarata, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
859 ≥ 72nd percentile 72% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Sandra Cammarata, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sandra Cammarata, MD?
Quality data not reportedPrimary specialty
Child & Adolescent Psychiatry Physician
Medicare Part D claims
859 41% vs specialty avg
Specialty distribution in New Jersey
How Child & Adolescent Psychiatry Physician compares to other specialties among New Jersey providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Child & Adolescent Psychiatry Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1215377338 |
|---|---|
| Specialty | Child & Adolescent Psychiatry Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/03/2013 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sandra Cammarata, MD. Source: openpaymentsdata.cms.gov.
Total received
$125
Largest payer
Cleerly, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Sandra Cammarata, MD - brand share 16.0%
Child & Adolescent Psychiatry Physician average
16% brand-name claims vs 84% generic, on 859 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
859
Total Claims
$101K
Total Drug Cost
53
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,068.967
- Total Day Supply
- 30,597
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $80K
- Generic Drug Cost
- $21K
Patient Demographics
- Average Patient Age
- 68.1 years
- Avg HCC Risk Score
- 1.05
- Gender Split
- 64% female / 36% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Sandra Cammarata, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Clonazepam
Clonazepam
90 claims
- Duloxetine Hcl
Duloxetine Hcl
87 claims
- Dextroamphetamine-…
Dextroamphetamine-Amphet Er
66 claims
- Mirtazapine
Mirtazapine
64 claims
- Bupropion Xl
Bupropion Xl
51 claims
- Dextroamphetamine-…
Dextroamphetamine-Amphetamine
49 claims
- Alprazolam
Alprazolam
38 claims
- Fluoxetine Hcl
Fluoxetine Hcl
38 claims
| Drug | Claims |
|---|---|
| Clonazepam | 90 |
| Duloxetine Hcl | 87 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 66 |
| Mirtazapine | 64 |
| Bupropion Xl Bupropion Hcl | 51 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 49 |
| Alprazolam | 38 |
| Fluoxetine Hcl | 38 |
| Trintellix Vortioxetine Hydrobromide | 34 |
| Vyvanse Lisdexamfetamine Dimesylate | 31 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Child & Adolescent Psychiatry Physician in NJ →
All providers in New Jersey →
Compare specialties →
Child & Adolescent Psychiatry Physician Overview
How Sandra Cammarata, MD fits within the Child & Adolescent Psychiatry Physician landscape nationally.
6,300
Child & Adolescent Psychiatry Physician Providers in US
54
States with Child & Adolescent Psychiatry Physician
608
Avg Claims per Provider
Sandra Cammarata, MD's 859 claims are above the specialty average of 608.
Nationwide Child & Adolescent Psychiatry Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Cammarata, both outside New Jersey so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Child & Adolescent Psychiatry Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Cammarata.
One of 180 Child & Adolescent Psychiatry Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Jennifer Abramson
MD
Maplewood, NJ
Dr. Oluwabukola Adasofunjo
M.D.
Maywood, NJ
Lara Addesso
Morristown, NJ
Dr. Ayesha Adil
M.D.
Trenton, NJ
Eric Agbagbey
Westampton, NJ
Compare Child & Adolescent Psychiatry Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Sandra Cammarata, MD's specialty? ▼
Sandra Cammarata, MD specializes in Child & Adolescent Psychiatry Physician and practices in Caldwell, New Jersey. Credentials: MD.
How much does Sandra Cammarata, MD prescribe under Medicare Part D? ▼
In 2024, Sandra Cammarata, MD wrote 859 Medicare Part D claims totaling $101K in drug costs for 53 beneficiaries.
Where is Sandra Cammarata, MD located? ▼
Sandra Cammarata, MD is located at 14 SMULL AVE, Caldwell, NJ, 07006. Phone: (973) 618-0100.
What is Sandra Cammarata, MD's NPI number? ▼
Sandra Cammarata, MD's National Provider Identifier (NPI) is 1215377338, issued on 07/03/2013.
Does Sandra Cammarata, MD prescribe more brand-name or generic drugs? ▼
Sandra Cammarata, MD's prescribing is 16% brand-name and 84% generic drugs by claim count, with $80K in brand drug costs.
How many Child & Adolescent Psychiatry Physician providers are there in the US? ▼
There are 6,300 Child & Adolescent Psychiatry Physician providers across 54 states in the US. The average Child & Adolescent Psychiatry Physician provider writes 608 Medicare Part D claims per year.
What drugs does Sandra Cammarata, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Sandra Cammarata, MD's most frequently prescribed drugs include Clonazepam, Duloxetine Hcl, Dextroamphetamine-Amphet Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sandra Cammarata, MD accept Medicare? ▼
Sandra Cammarata, MD appears in CMS Medicare data with 859 Part D claims and 53 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sandra Cammarata, MD's credentials? ▼
Sandra Cammarata, MD's NPI is 1215377338 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.